Filing Flows

Filing Flows › 8-K events › Baxter International

Baxter International: results of operations

Form 8-K filed Oct 29, 2026 · items 2.02, 8.01

Results of operationsBAXTER REPORTS THIRD-QUARTER 2026 RESULTS

What the filing says

• Third-quarter sales of $2.98 billion increased 5% on both a reported and organic basis, 1,2 reflecting growth in all segments and divisions GAAP 3 diluted earnings per share (EPS) of $0.57; adjusted diluted EPS of $0.58 1

ScaleThe filing names $2.98B: about 25% of Baxter International's annual revenue ($11.90B, four times the latest quarter).

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Item 8.01: +0.1% next session across 44,881. Every item ranked →

Baxter International at a glance

Latest quarterQ3 2026
Revenue$3.0B
Revenue Y/Y+5%
Operating margin7.6%
IndustrySurgical & Medical Instruments & Apparatus

Baxter International, Q3 2026: revenue $3.0B (+5% year over year), operating margin 7.6%. The chart follows the revenue to costs, profit and cash.

Baxter International: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent guidance

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.